Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 10098755)

1.

A high incidence of vertebral fracture in women with breast cancer.

Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T.

Br J Cancer. 1999 Mar;79(7-8):1179-81.

2.

Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis.

McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, Beneton M, Kanis JA, Charlesworth D.

J Bone Miner Res. 2008 Oct;23(10):1561-8. doi: 10.1359/jbmr.080515.

PMID:
18505372
3.

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

Dearnaley DP, Sydes MR, Mason MD, Stott M, Powell CS, Robinson AC, Thompson PM, Moffat LE, Naylor SL, Parmar MK; Mrc Pr05 Collaborators.

J Natl Cancer Inst. 2003 Sep 3;95(17):1300-11.

4.

Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.

McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Kayan K, Beneton M, Jalava T, Pylkkänen L, Kenraali J, Aropuu S, Kanis JA.

J Bone Miner Res. 2004 May;19(5):728-36. Epub 2004 Jan 19.

PMID:
15068495
5.

Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer.

Rizzoli R, Forni M, Schaad MA, Slosman DO, Sappino AP, Garcia J, Bonjour JP.

Bone. 1996 Jun;18(6):531-7.

PMID:
8805993
6.

Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.

Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr.

J Am Geriatr Soc. 2004 Sep;52(9):1543-8.

PMID:
15341559
7.

A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.

Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A.

Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420. Review.

8.

Clodronate decreases the frequency of skeletal metastases in women with breast cancer.

Kanis JA, Powles T, Paterson AH, McCloskey EV, Ashley S.

Bone. 1996 Dec;19(6):663-7.

PMID:
8968035
9.

Treatment of skeletal disease in breast cancer with clodronate.

Paterson AH, Ernst DS, Powles TJ, Ashley S, McCloskey EV, Kanis JA.

Bone. 1991;12 Suppl 1:S25-30. Review.

PMID:
1720012
10.

The assessment of vertebral deformity: a method for use in population studies and clinical trials.

McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA.

Osteoporos Int. 1993 May;3(3):138-47.

PMID:
8481590
11.

Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women.

Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD.

Osteoporos Int. 1993 May;3(3):120-6.

PMID:
8481587
12.

High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy.

Bouvard B, Hoppé E, Soulié P, Georgin-Mege M, Jadaud E, Abadie-Lacourtoisie S, Petit Le Manac'h A, Laffitte A, Levasseur R, Audran M, Chappard D, Legrand E.

Ann Oncol. 2012 May;23(5):1151-6. doi: 10.1093/annonc/mdr356. Epub 2011 Sep 7.

13.

[Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].

Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.

Bull Cancer. 2001 Jul;88(7):701-7. French.

PMID:
11495824
14.

Vertebral fractures: a hidden problem of osteoporosis.

Haczynski J, Jakimiuk A.

Med Sci Monit. 2001 Sep-Oct;7(5):1108-17. Review.

PMID:
11535963
15.

Fracture in asian women with breast cancer occurs at younger age.

Tsai CH, Muo CH, Tzeng HE, Tang CH, Hsu HC, Sung FC.

PLoS One. 2013 Sep 12;8(9):e75109. doi: 10.1371/journal.pone.0075109. eCollection 2013. Erratum in: PLoS One. 2013;8(9). 10.1371/annotation/da898acf-fd59-480d-bea1-c91d13f43a5c. Tsa, Chun-Hao [corrected to Tsai, Chun-Hao].

16.

Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysis.

McCloskey E, Selby P, de Takats D, Bernard J, Davies M, Robinson J, Francis R, Adams J, Pande K, Beneton M, Jalava T, Löyttyniemi E, Kanis JA.

Bone. 2001 Mar;28(3):310-5.

PMID:
11248662
17.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
18.

Epidemiology of vertebral osteoporosis.

Kanis JA, McCloskey EV.

Bone. 1992;13 Suppl 2:S1-10. Review.

PMID:
1385718
19.
20.

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.

Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S.

J Clin Oncol. 1993 Jan;11(1):59-65.

PMID:
8418243
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk